⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1332926 | 1.00 | — | — | |
| SCHEMBL17769312 | 0.89 | HSD17B10 (0.40) | — | |
| SCHEMBL7535158 | 0.89 | CA1 (0.41) | — | |
| SCHEMBL9447834 | 0.86 | CA1 (0.39) | — | |
| SCHEMBL9447829 | 0.86 | CA1 (0.39) | — | |
| SCHEMBL3485216 | 0.84 | HSD17B10 (0.37) | — | |
| SCHEMBL202567 | 0.83 | CA1 (0.45) | — | |
| SCHEMBL23559507 | 0.82 | — | — | |
| SCHEMBL5021528 | 0.82 | — | — | |
| SCHEMBL5832062 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0176991-A1 | Composition and method for corrosion inhibition | PHILLIPS PETROLEUM COMPANY (US) | 1986-04-09 | — | — | EP | claimed |
| JP-6056811-A | — | — | None | — | — | JP | disclosed |
| US-12583853-B2 | 1H-pyrrolo[2,3-b]pyridine derivatives and related compounds as BCL-2 inhibitors for the treatment of neoplastic and autoimmune diseases | NEWAVE PHARMACEUTICAL INC. (US) | 2026-03-24 | — | — | US | disclosed |
| US-12552784-B2 | 1H-pyrrolo[2,3-b]pyridine derivatives as BCL-2 inhibitors for the treatment of neoplastic and autoimmune diseases | NEWAVE PHARMACEUTICAL INC. (US) | 2026-02-17 | — | — | US | disclosed |
| US-20250114374-A1 | BCL-2 INHIBITORS | NEWAVE PHARMACEUTICAL INC. | 2025-04-10 | — | — | US | disclosed |
| US-12220419-B2 | BCL-2 inhibitors | NEWAVE PHARMACEUTICAL INC. (US) | 2025-02-11 | — | — | US | disclosed |
| US-20240180924-A1 | BCL-2 INHIBITORS | NEWAVE PHARMACEUTICAL INC. | 2024-06-06 | — | — | US | disclosed |
| US-20240166646-A1 | 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES | NEWAVE PHARMACEUTICAL INC. | 2024-05-23 | — | — | US | disclosed |
| US-11903950-B2 | BCL-2 inhibitors | NEWAVE PHARMACEUTICAL INC. (US) | 2024-02-20 | — | — | US | disclosed |
| US-20230295183-A1 | HOT MELT EXTRUDED SOLID DISPERSIONS CONTAINING A BCL2 INHIBITOR | NEWAVE PHARMACEUTICAL INC. | 2023-09-21 | — | — | US | disclosed |
| JP-H0656811-A | PRODUCTION OF GLYCIDYL VINYL ETHER | SEIMI CHEM CO LTD | 1994-03-01 | — | — | JP | disclosed |
| US-5093432-A | Perfluorination of esters or ethers | EXFLUOR RESEARCH CORPORATION (US) | 1992-03-03 | — | — | US | disclosed |
| EP-0441807-A1 | LIQUID PHASE FLUORINATION. | EXFLUOR RES CORP (US) | 1991-08-21 | — | — | EP | disclosed |
| EP-0436669-A1 | PERFLUOROACETAL AND PERFLUOROKETAL COMPOUNDS AND USE THEREOF IN THERMAL SHOCK TESTING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-07-17 | — | — | EP | disclosed |
| WO-1990003357-A1 | PERFLUOROACETAL AND PERFLUOROKETAL COMPOUNDS AND USE THEREOF IN THERMAL SHOCK TESTING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-04-05 | — | — | WO | disclosed |
| WO-1990003353-A1 | LIQUID PHASE FLUORINATION | EXFLUOR RESEARCH CORPORATION (US) | 1990-04-05 | — | — | WO | disclosed |
| EP-0137182-B1 | PROCESS FOR THE FABRICATION OF POSSIBLY CELLULAR POLYURETHANES | BAYER AG (DE) | 1986-10-15 | — | — | EP | disclosed |
| EP-0176991-A1 | Composition and method for corrosion inhibition | PHILLIPS PETROLEUM COMPANY (US) | 1986-04-09 | — | — | EP | disclosed |
| EP-0137182-A1 | Process for the fabrication of possibly cellular polyurethanes | BAYER AG (DE) | 1985-04-17 | — | — | EP | disclosed |
| US-4510269-A | POLY-DIALKYLAMINOALKYL-ETHER CATALYST | BAYER AKTIENGESELLSCHAFT (DE) | 1985-04-09 | — | — | US | disclosed |